Vı́ctor Navarro

2.5k total citations
64 papers, 1.6k citations indexed

About

Vı́ctor Navarro is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Vı́ctor Navarro has authored 64 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 11 papers in Molecular Biology and 10 papers in Pharmacology. Recurrent topics in Vı́ctor Navarro's work include Drug-Induced Hepatotoxicity and Protection (10 papers), Treatment of Major Depression (7 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Vı́ctor Navarro is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (10 papers), Treatment of Major Depression (7 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Vı́ctor Navarro collaborates with scholars based in Spain, United States and Palestinian Territory. Vı́ctor Navarro's co-authors include Cristòbal Gastó, Luís Pintor, Manuel Tena‐Sempere, Xavier Torres, Kitt Falk Petersen, Gerald I. Shulman, Lourdes Fañanás, Joana Guarch, Rafael Penadés and Rosa Catalán and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Vı́ctor Navarro

59 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vı́ctor Navarro Spain	22	332	263	248	225	179	64	1.6k
Michelle Rose United States	28	684 2.1×	286 1.1×	231 0.9×	138 0.6×	215 1.2×	43	2.4k
Hua Hu China	25	588 1.8×	155 0.6×	99 0.4×	107 0.5×	120 0.7×	121	1.7k
Ilkka Julkunen Finland	16	576 1.7×	297 1.1×	269 1.1×	71 0.3×	215 1.2×	29	2.2k
Jessica Mwinyi Sweden	25	646 1.9×	264 1.0×	255 1.0×	161 0.7×	312 1.7×	75	2.0k
Naomi Saito United States	20	158 0.5×	247 0.9×	158 0.6×	45 0.2×	187 1.0×	54	1.3k
Ling Shen United States	34	1.1k 3.4×	651 2.5×	226 0.9×	98 0.4×	253 1.4×	132	3.7k
Mark Barnes United States	17	369 1.1×	489 1.9×	154 0.6×	50 0.2×	62 0.3×	30	1.5k
Nobuya Ogawa Japan	29	536 1.6×	177 0.7×	134 0.5×	267 1.2×	351 2.0×	157	2.5k
Tae Suk Kim South Korea	21	248 0.7×	340 1.3×	147 0.6×	154 0.7×	101 0.6×	56	1.6k
Susan M. Wood United Kingdom	28	387 1.2×	522 2.0×	294 1.2×	146 0.6×	254 1.4×	76	2.5k

Countries citing papers authored by Vı́ctor Navarro

Since Specialization

Citations

This map shows the geographic impact of Vı́ctor Navarro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vı́ctor Navarro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vı́ctor Navarro more than expected).

Fields of papers citing papers by Vı́ctor Navarro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vı́ctor Navarro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vı́ctor Navarro. The network helps show where Vı́ctor Navarro may publish in the future.

Co-authorship network of co-authors of Vı́ctor Navarro

This figure shows the co-authorship network connecting the top 25 collaborators of Vı́ctor Navarro. A scholar is included among the top collaborators of Vı́ctor Navarro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vı́ctor Navarro. Vı́ctor Navarro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Navarro, Vı́ctor, Moraima Jiménez, Marc Bosch, et al.. (2025). Impact of SARS-CoV-2 infection on bispecific antibody treatment in patients with B-cell lymphoproliferative disorders. Blood Advances. 9(16). 4180–4189. 1 indexed citations

Bastos‐Oreiro, Mariana, Gloria Iacoboni, Vı́ctor Navarro, et al.. (2025). Chimeric antigen receptor T‐cell therapy outcomes in T cell/histiocyte‐rich large B‐cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study. HemaSphere. 9(2). e70077–e70077. 1 indexed citations

Li, Yi‐Ju, Jawad Ahmad, Huiman X. Barnhart, et al.. (2024). Clinical characteristics and HLA associations of azithromycin‐induced liver injury. Alimentary Pharmacology & Therapeutics. 60(6). 787–795. 7 indexed citations

Navarro, Vı́ctor, Marta Ligero, Alonso García-Ruiz, et al.. (2024). Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in Cancer. Radiology Artificial Intelligence. 6(2). e230118–e230118. 15 indexed citations

Villacampa, Guillermo, Vı́ctor Navarro, Alexios Matikas, et al.. (2024). Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Early Breast Cancer. JAMA Oncology. 10(10). 1331–1331. 29 indexed citations

Navarro, Vı́ctor, Gloria Iacoboni, Juan‐Manuel Sancho, et al.. (2024). Rituximab maintenance after bendamustine-based treatment for follicular lymphoma and mantle cell lymphoma may exert a negative influence on SARS-CoV-2 infection outcomes. Haematologica. 110(1). 173–178. 1 indexed citations

Castet, Florian, Vı́ctor Navarro, Daniel Acosta, et al.. (2023). Clinical and genomic characterisation of early-onset pancreatic cancer. European Journal of Cancer. 194. 113338–113338. 11 indexed citations

Serrano, César, Guillermo Villacampa, Michael C. Heinrich, et al.. (2023). Rethinking placebos: embracing synthetic control arms in clinical trials for rare tumors. Nature Medicine. 29(11). 2689–2692. 11 indexed citations

Iacoboni, Gloria, Berta Pernas, Juliana Esperalba, et al.. (2022). Impact of Cytomegalovirus Replication in Patients with Aggressive B Cell Lymphoma Treated with Chimeric Antigen Receptor T Cell Therapy. Transplantation and Cellular Therapy. 28(12). 851.e1–851.e8. 30 indexed citations

10.

Palma‐Gudiel, Helena, Aldo Córdova‐Palomera, Vı́ctor Navarro, & Lourdes Fañanás. (2020). Twin study designs as a tool to identify new candidate genes for depression: A systematic review of DNA methylation studies. Neuroscience & Biobehavioral Reviews. 112. 345–352. 9 indexed citations

11.

Navarro, Vı́ctor, et al.. (2019). Lithium Augmentation Versus Citalopram Combination in Imipramine-Resistant Major Depression. Journal of Clinical Psychopharmacology. 39(3). 254–257. 5 indexed citations

12.

Verma, Manisha, Shana D. Stites, & Vı́ctor Navarro. (2017). Bringing Assessment of Patient-Reported Outcomes to Hepatology Practice. Clinical Gastroenterology and Hepatology. 16(3). 447–448. 10 indexed citations

13.

Córdova‐Palomera, Aldo, Mar Fatjó‐Vilas, Cristòbal Gastó, et al.. (2015). Genome-wide methylation study on depression: differential methylation and variable methylation in monozygotic twins. Translational Psychiatry. 5(4). e557–e557. 78 indexed citations

14.

Navarro, Vı́ctor, Cristòbal Gastó, Joana Guarch, Rafael Penadés, & Luís Pintor. (2013). Treatment and outcome of antidepressant treatment-associated hypomania in unipolar major depression: A 3-year follow-up study. Journal of Affective Disorders. 155. 59–64. 6 indexed citations

15.

Navarro, Vı́ctor, Alexandre González-Rodríguez, Joana Guarch, et al.. (2013). Association between symptomatic profile and remission following antidepressant treatment in unipolar major depression. Journal of Affective Disorders. 150(2). 209–215. 6 indexed citations

16.

Navarro, Vı́ctor, et al.. (2010). Terapia dialéctica comportamental (DBT) en un caso con rasgos de personalidad límite y trastorno de la conducta alimentaria / Dialectical behavior therapy in a case of borderline personality disorder traits and eating disorder. Revista de Psicopatología y Psicología Clínica. 15(1). 61–74. 3 indexed citations

17.

Rojas, Gabriela, et al.. (2006). Effectiveness and Tolerability of a Standardized Extract from Ageratina pichinchensis on Patients with Tinea Pedis: An Explorative Pilot Study Controlled with Ketoconazole. Planta Medica. 72(14). 1257–1261. 16 indexed citations

18.

Pintor, Luís, Xavier Torres, Vı́ctor Navarro, Silvia Matrai, & Cristòbal Gastó. (2004). Is the type of remission after a major depressive episode an important risk factor to relapses in a 4-year follow up?. Journal of Affective Disorders. 82(2). 291–296. 60 indexed citations

19.

Blanch, Jordi, Araceli Rousaud, Estebán Martínez, et al.. (2004). Factors Associated with Severe Impact of Lipodystrophy on the Quality of Life of Patients Infected with HIV-1. Clinical Infectious Diseases. 38(10). 1464–1470. 72 indexed citations

20.

Farra, Claude Dal, Philippe Sarret, Vı́ctor Navarro, et al.. (2001). Involvement of the neurotensin receptor subtype NTR3 in the growth effect of neurotensin on cancer cell lines. International Journal of Cancer. 92(4). 503–509. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact